US approves 1st drug developed to prevent chronic migraines - WAFB 9 News Baton Rouge, Louisiana News, Weather, Sports

US approves 1st drug developed to prevent chronic migraines

By LINDA A. JOHNSON
AP Medical Writer

TRENTON, N.J. (AP) - U.S. regulators Thursday approved the first drug designed to prevent chronic migraines.

The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are being tested.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don't help much or cause serious side effects.

Amgen Inc. of Thousand Oaks, California, and Swiss drug giant Novartis AG developed Aimovig. Injected monthly just under the skin using a penlike device, the drug will cost $6,900 per year without insurance.

Migraines can cause disabling symptoms: throbbing headaches, nausea and vomiting, and sensitivity to light and sound. About 10 million Americans get them frequently. They're most common in people in their 30s, mostly women, and can last for several hours or even days.

In one study, patients given Aimovig saw their migraine days cut from eight to four a month, on average. Those who got dummy shots had a reduction of two. Each patient group had similar minor side effects, mostly colds and respiratory infections.

Some patients saw their migraines completely eliminated, said Sean Harper, Amgen's research director.

Aimovig and the migraine drugs in development target a substance called CGRP whose levels spike in the blood during a migraine, triggering symptoms.

The long-term safety of Aimovig, also known as erenumab, hasn't been tested, and Amgen plans to track outcomes in women who become pregnant while taking it.

___

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • NationalMore>>

  • Senate hopeful Joe Arpaio mum on details of Trump policies

    Senate hopeful Joe Arpaio mum on details of Trump policies

    Tuesday, May 22 2018 7:23 PM EDT2018-05-22 23:23:02 GMT
    Wednesday, May 23 2018 7:16 AM EDT2018-05-23 11:16:19 GMT
    (AP Photo/Matt York). Former Arizona Sheriff Joe Arpaio arrives Tuesday, May 22, 2018 at the Arizona Secretary of State's office in Phoenix to turn in petition signatures in his bid to appear on the ballot in the race to succeed retiring U.S. Sen. Jeff...(AP Photo/Matt York). Former Arizona Sheriff Joe Arpaio arrives Tuesday, May 22, 2018 at the Arizona Secretary of State's office in Phoenix to turn in petition signatures in his bid to appear on the ballot in the race to succeed retiring U.S. Sen. Jeff...
    U.S. Senate candidate Joe Arpaio has pledged his unwavering support for President Donald Trump but is unwilling or unable to elaborate on the president's policies.More >>
    U.S. Senate candidate Joe Arpaio has pledged his unwavering support for President Donald Trump but is unwilling or unable to elaborate on the president's policies.More >>
  • Wyoming makes rush for hyped new tech, results still virtual

    Wyoming makes rush for hyped new tech, results still virtual

    Wednesday, May 23 2018 3:03 AM EDT2018-05-23 07:03:06 GMT
    Wednesday, May 23 2018 7:15 AM EDT2018-05-23 11:15:44 GMT
    (AP Photo/Mead Gruver). In this March 8, 2018 photo Wyoming state Rep. Tyler Lindholm poses next to computer servers in an office building in Cheyenne, Wyo. Lindholm was a lead proponent of several new laws that have made Wyoming friendly to the networ...(AP Photo/Mead Gruver). In this March 8, 2018 photo Wyoming state Rep. Tyler Lindholm poses next to computer servers in an office building in Cheyenne, Wyo. Lindholm was a lead proponent of several new laws that have made Wyoming friendly to the networ...
    Companies flock to register in Wyoming after bold push for hyped new technology but results remain virtual.More >>
    Companies flock to register in Wyoming after bold push for hyped new technology but results remain virtual.More >>
  • Philip Roth, fearless and celebrated author, dies at 85

    Philip Roth, fearless and celebrated author, dies at 85

    Wednesday, May 23 2018 12:03 AM EDT2018-05-23 04:03:23 GMT
    Wednesday, May 23 2018 7:14 AM EDT2018-05-23 11:14:50 GMT
    (AP Photo/Richard Drew, File). FILE - In this Sept. 8, 2008, file photo, author Philip Roth poses for a photo in the offices of his publisher, Houghton Mifflin, in New York. Roth, prize-winning novelist and fearless narrator of sex, religion and mortal...(AP Photo/Richard Drew, File). FILE - In this Sept. 8, 2008, file photo, author Philip Roth poses for a photo in the offices of his publisher, Houghton Mifflin, in New York. Roth, prize-winning novelist and fearless narrator of sex, religion and mortal...

    Author of more than 25 books,  Philip Roth won virtually every literary honor, including the Pulitzer Prize for "American Pastoral."

    More >>

    Author of more than 25 books,  Philip Roth won virtually every literary honor, including the Pulitzer Prize for "American Pastoral."

    More >>
Powered by Frankly